tiprankstipranks
Hikma Pharmaceuticals PLC (GB:HIK)
LSE:HIK

Compare Hikma Pharmaceuticals (HIK) vs. Competitors

118 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Hikma Pharmaceuticals
1554.00 p
£2.86B
11.21
-27.79%
2 Buy
0 Hold
1 Sell
Moderate Buy
Allergy Therapeutics
11.80 p
£683.91M
-7.21
105.71%
Shield Therapeutics
9.85 p
£100.86M
-4.82
248.15%
Venture Life
65.50 p
£79.80M
2.80
59.76%
Beximco Pharmaceuticals Limited Sponsored GDR RegS
42.50 p
52.37B
4.42
11.84%
Haleon PLC
360.50 p
£32.46B
20.15
-3.74%
9 Buy
1 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:HIK
Hikma Pharmaceuticals
1,321.50
-468.60
-26.18%
GB:AGY
Allergy Therapeutics
10.80
5.10
89.47%
GB:STX
Shield Therapeutics
9.40
6.65
241.82%
GB:VLG
Venture Life
65.50
25.00
61.73%
GB:BXP
Beximco Pharmaceuticals Limited Sponsored GDR RegS
42.50
4.50
11.84%
GB:HLN
Haleon PLC
360.50
-6.68
-1.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts